| STUDY | ACCR. GOAL |
R E G |
O P E N |
ARM | TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S1703-Met Breast, STM-monitoring v Usual Care | 498 | 2 | Y | 1 Control (Usual Care) | 236 | 23 | 10 | 5 | 0 | 0 | 09/17/2018 | 248 | 91 |
| 2 Intervention (STMDDM) | 241 | 25 | 12 | 3 | 1 | 0 | 09/17/2018 | 248 | 91 | ||||
| 477 | 48 | 22 | 8 | 1 | 0 | ||||||||
| S2417CD-Colrec Surv, Follow-up w/ CTAC site | 654 | 1 | Y | 1 CTAC Intervention | 93 | 92 | 56 | 28 | 9 | 1 | 10/15/2025 | 161 | 45 |
| 2 CTAC Control | 47 | 47 | 25 | 10 | 5 | 2 | 10/15/2025 | 161 | 45 | ||||
| 140 | 139 | 81 | 38 | 14 | 3 | ||||||||
| S2424CD-A-PACT vs SOC for GOC communication | 1000 | 1 | Y | Blinded Drug | 9 | 9 | 9 | 9 | 5 | 2 | 08/07/2026 | 58 | 15 |
| 9 | 9 | 9 | 9 | 5 | 2 | ||||||||
| A231602C-Blood Cancer, Assess Financial Difficulty | 1 | T | 4 | 0 | 0 | 0 | 0 | 0 | 06/04/2020 | ||||
| 4 | 0 | 0 | 0 | 0 | 0 | ||||||||
| ACCL16N1-Guideline Consistent Treatment AYA ALL | 1 | T | 54 | 0 | 0 | 0 | 0 | 0 | 10/24/2018 | ||||
| 54 | 0 | 0 | 0 | 0 | 0 | ||||||||